https://shannonchristy.wordpress.com/2011/04/14/no-class-i-think-ill-kayak/

On-Site Reporting from NAS Public Meeting Last Week

by Barbara Weinstein Downstream Consequences of Aging is a bi-monthly series written by guest columnist Barbara Weinstein, PhD.  Today’s post gives readers a sense of the simultaneous breathless drama and grinding diligence experienced by all participating stakeholders at last week’s pivotal NAS meeting.   The Plenary: Sounds of Silence   At the Dec. 7, 2016 Dissemination…

Read More

A Bayesian Approach to Cost Effective Hearing Care: What Audiologists Could Learn from Election Gurus

“Signal & Noise” is a bimonthly column by Brian Taylor, AuD.   During the 2008 election, data guru Nate Silver and his website FiveThirtyEight accurately predicted the winner of the presidential election in 49 of 50 states. After tweaking his data analysis methods he did even better in the 2012 presidential race by accurately predicting…

Read More

Barriers? We Don’t Got No Stinking Barriers!

“There are no barriers [that discourage new entrants to the hearing aid industry].  New entrants simply have to comply with regulations intended to safeguard our patients. This excerpt from a recent post on the PCAST report gives pause, prompting switching of hats from Audiologist to Economist. Though Hearing Economics has written on market barriers before,…

Read More
http://surbrook.devermore.net/adaptationsmovie/madmax/max_thunderdome.html

Survival of the Fittest Audiologists

  Last post introduced readers to Tom Northey and his 2000 forecast of Audiology in the future, which predicted that today’s audiologists would fall into camps of survivors or  scatter to the wind as competitive forces eased out the losers.  Today’s post is for those of us interested in operating in survivor mode. Northey contrasted our…

Read More

Regulation of Hearing Aids in the US, part 7 (the end!)

  Back to the Future:  Current Thinking at the FDA and in the Marketplace The burden of regulation continues to haunt the hearing aid industry and cost consumers.  Notwithstanding the entrenched regulatory mentality described in Parts 5 and 6 of this series, there were two interesting Citizen’s Petitions that were filed with the FDA in…

Read More